Global Antibiotics Market Insights, Forecast to 2028

Publisher Name :
Date: 17-Mar-2022
No. of pages: 105
Inquire Before Buying

Antibiotics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Cephalosporins

- Penicillins

- Fluoroquinolones

- Macrolides

- Carbapenems

- Aminoglycosides

- Sulfonamides

- Others

Segment by Application

- Hospital

- Clinics

- Others

By Company

- Pfizer

- Janssen Pharmaceuticals

- Abbott

- GlaxoSmithKline

- Sanofi

- Novartis

- Bayer

- Bristol Myers Squibb Company

- Eli Lilly and Company

- Astellas Pharma

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Antibiotics Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Antibiotics Product Introduction
1.2 Market by Type
1.2.1 Global Antibiotics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cephalosporins
1.2.3 Penicillins
1.2.4 Fluoroquinolones
1.2.5 Macrolides
1.2.6 Carbapenems
1.2.7 Aminoglycosides
1.2.8 Sulfonamides
1.2.9 Others
1.3 Market by Application
1.3.1 Global Antibiotics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibiotics Sales Estimates and Forecasts 2017-2028
2.2 Global Antibiotics Revenue Estimates and Forecasts 2017-2028
2.3 Global Antibiotics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antibiotics Sales by Region
2.4.1 Global Antibiotics Sales by Region (2017-2022)
2.4.2 Global Sales Antibiotics by Region (2023-2028)
2.5 Global Antibiotics Revenue by Region
2.5.1 Global Antibiotics Revenue by Region (2017-2022)
2.5.2 Global Antibiotics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibiotics Sales by Manufacturers
3.1.1 Global Top Antibiotics Manufacturers by Sales (2017-2022)
3.1.2 Global Antibiotics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibiotics in 2021
3.2 Global Antibiotics Revenue by Manufacturers
3.2.1 Global Antibiotics Revenue by Manufacturers (2017-2022)
3.2.2 Global Antibiotics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antibiotics Revenue in 2021
3.3 Global Antibiotics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibiotics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibiotics Sales by Type
4.1.1 Global Antibiotics Historical Sales by Type (2017-2022)
4.1.2 Global Antibiotics Forecasted Sales by Type (2023-2028)
4.1.3 Global Antibiotics Sales Market Share by Type (2017-2028)
4.2 Global Antibiotics Revenue by Type
4.2.1 Global Antibiotics Historical Revenue by Type (2017-2022)
4.2.2 Global Antibiotics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antibiotics Revenue Market Share by Type (2017-2028)
4.3 Global Antibiotics Price by Type
4.3.1 Global Antibiotics Price by Type (2017-2022)
4.3.2 Global Antibiotics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antibiotics Sales by Application
5.1.1 Global Antibiotics Historical Sales by Application (2017-2022)
5.1.2 Global Antibiotics Forecasted Sales by Application (2023-2028)
5.1.3 Global Antibiotics Sales Market Share by Application (2017-2028)
5.2 Global Antibiotics Revenue by Application
5.2.1 Global Antibiotics Historical Revenue by Application (2017-2022)
5.2.2 Global Antibiotics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antibiotics Revenue Market Share by Application (2017-2028)
5.3 Global Antibiotics Price by Application
5.3.1 Global Antibiotics Price by Application (2017-2022)
5.3.2 Global Antibiotics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antibiotics Market Size by Type
6.1.1 North America Antibiotics Sales by Type (2017-2028)
6.1.2 North America Antibiotics Revenue by Type (2017-2028)
6.2 North America Antibiotics Market Size by Application
6.2.1 North America Antibiotics Sales by Application (2017-2028)
6.2.2 North America Antibiotics Revenue by Application (2017-2028)
6.3 North America Antibiotics Market Size by Country
6.3.1 North America Antibiotics Sales by Country (2017-2028)
6.3.2 North America Antibiotics Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antibiotics Market Size by Type
7.1.1 Europe Antibiotics Sales by Type (2017-2028)
7.1.2 Europe Antibiotics Revenue by Type (2017-2028)
7.2 Europe Antibiotics Market Size by Application
7.2.1 Europe Antibiotics Sales by Application (2017-2028)
7.2.2 Europe Antibiotics Revenue by Application (2017-2028)
7.3 Europe Antibiotics Market Size by Country
7.3.1 Europe Antibiotics Sales by Country (2017-2028)
7.3.2 Europe Antibiotics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibiotics Market Size by Type
8.1.1 Asia Pacific Antibiotics Sales by Type (2017-2028)
8.1.2 Asia Pacific Antibiotics Revenue by Type (2017-2028)
8.2 Asia Pacific Antibiotics Market Size by Application
8.2.1 Asia Pacific Antibiotics Sales by Application (2017-2028)
8.2.2 Asia Pacific Antibiotics Revenue by Application (2017-2028)
8.3 Asia Pacific Antibiotics Market Size by Region
8.3.1 Asia Pacific Antibiotics Sales by Region (2017-2028)
8.3.2 Asia Pacific Antibiotics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antibiotics Market Size by Type
9.1.1 Latin America Antibiotics Sales by Type (2017-2028)
9.1.2 Latin America Antibiotics Revenue by Type (2017-2028)
9.2 Latin America Antibiotics Market Size by Application
9.2.1 Latin America Antibiotics Sales by Application (2017-2028)
9.2.2 Latin America Antibiotics Revenue by Application (2017-2028)
9.3 Latin America Antibiotics Market Size by Country
9.3.1 Latin America Antibiotics Sales by Country (2017-2028)
9.3.2 Latin America Antibiotics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antibiotics Market Size by Type
10.1.1 Middle East and Africa Antibiotics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antibiotics Revenue by Type (2017-2028)
10.2 Middle East and Africa Antibiotics Market Size by Application
10.2.1 Middle East and Africa Antibiotics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antibiotics Revenue by Application (2017-2028)
10.3 Middle East and Africa Antibiotics Market Size by Country
10.3.1 Middle East and Africa Antibiotics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antibiotics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Corporation Information
11.2.2 Janssen Pharmaceuticals Overview
11.2.3 Janssen Pharmaceuticals Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Janssen Pharmaceuticals Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Janssen Pharmaceuticals Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Bristol Myers Squibb Company
11.8.1 Bristol Myers Squibb Company Corporation Information
11.8.2 Bristol Myers Squibb Company Overview
11.8.3 Bristol Myers Squibb Company Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol Myers Squibb Company Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol Myers Squibb Company Recent Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Corporation Information
11.9.2 Eli Lilly and Company Overview
11.9.3 Eli Lilly and Company Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly and Company Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly and Company Recent Developments
11.10 Astellas Pharma
11.10.1 Astellas Pharma Corporation Information
11.10.2 Astellas Pharma Overview
11.10.3 Astellas Pharma Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Astellas Pharma Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Astellas Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antibiotics Industry Chain Analysis
12.2 Antibiotics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibiotics Production Mode & Process
12.4 Antibiotics Sales and Marketing
12.4.1 Antibiotics Sales Channels
12.4.2 Antibiotics Distributors
12.5 Antibiotics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibiotics Industry Trends
13.2 Antibiotics Market Drivers
13.3 Antibiotics Market Challenges
13.4 Antibiotics Market Restraints
14 Key Findings in The Global Antibiotics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antibiotics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Cephalosporins
Table 3. Major Manufacturers of Penicillins
Table 4. Major Manufacturers of Fluoroquinolones
Table 5. Major Manufacturers of Macrolides
Table 6. Major Manufacturers of Carbapenems
Table 7. Major Manufacturers of Aminoglycosides
Table 8. Major Manufacturers of Sulfonamides
Table 9. Major Manufacturers of Others
Table 10. Global Antibiotics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Antibiotics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Antibiotics Sales by Region (2017-2022) & (K Units)
Table 13. Global Antibiotics Sales Market Share by Region (2017-2022)
Table 14. Global Antibiotics Sales by Region (2023-2028) & (K Units)
Table 15. Global Antibiotics Sales Market Share by Region (2023-2028)
Table 16. Global Antibiotics Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Antibiotics Revenue Market Share by Region (2017-2022)
Table 18. Global Antibiotics Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Antibiotics Revenue Market Share by Region (2023-2028)
Table 20. Global Antibiotics Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Antibiotics Sales Share by Manufacturers (2017-2022)
Table 22. Global Antibiotics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Global Antibiotics Revenue Share by Manufacturers (2017-2022)
Table 24. Antibiotics Price by Manufacturers (2017-2022) &(USD/Unit)
Table 25. Global Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotics as of 2021)
Table 27. Antibiotics Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Antibiotics Product Offered
Table 29. Date of Manufacturers Enter into Antibiotics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Antibiotics Sales by Type (2017-2022) & (K Units)
Table 32. Global Antibiotics Sales by Type (2023-2028) & (K Units)
Table 33. Global Antibiotics Sales Share by Type (2017-2022)
Table 34. Global Antibiotics Sales Share by Type (2023-2028)
Table 35. Global Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 36. Global Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 37. Global Antibiotics Revenue Share by Type (2017-2022)
Table 38. Global Antibiotics Revenue Share by Type (2023-2028)
Table 39. Antibiotics Price by Type (2017-2022) & (USD/Unit)
Table 40. Global Antibiotics Price Forecast by Type (2023-2028) & (USD/Unit)
Table 41. Global Antibiotics Sales by Application (2017-2022) & (K Units)
Table 42. Global Antibiotics Sales by Application (2023-2028) & (K Units)
Table 43. Global Antibiotics Sales Share by Application (2017-2022)
Table 44. Global Antibiotics Sales Share by Application (2023-2028)
Table 45. Global Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 46. Global Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 47. Global Antibiotics Revenue Share by Application (2017-2022)
Table 48. Global Antibiotics Revenue Share by Application (2023-2028)
Table 49. Antibiotics Price by Application (2017-2022) & (USD/Unit)
Table 50. Global Antibiotics Price Forecast by Application (2023-2028) & (USD/Unit)
Table 51. North America Antibiotics Sales by Type (2017-2022) & (K Units)
Table 52. North America Antibiotics Sales by Type (2023-2028) & (K Units)
Table 53. North America Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 54. North America Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 55. North America Antibiotics Sales by Application (2017-2022) & (K Units)
Table 56. North America Antibiotics Sales by Application (2023-2028) & (K Units)
Table 57. North America Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 58. North America Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 59. North America Antibiotics Sales by Country (2017-2022) & (K Units)
Table 60. North America Antibiotics Sales by Country (2023-2028) & (K Units)
Table 61. North America Antibiotics Revenue by Country (2017-2022) & (US$ Million)
Table 62. North America Antibiotics Revenue by Country (2023-2028) & (US$ Million)
Table 63. Europe Antibiotics Sales by Type (2017-2022) & (K Units)
Table 64. Europe Antibiotics Sales by Type (2023-2028) & (K Units)
Table 65. Europe Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 66. Europe Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 67. Europe Antibiotics Sales by Application (2017-2022) & (K Units)
Table 68. Europe Antibiotics Sales by Application (2023-2028) & (K Units)
Table 69. Europe Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 70. Europe Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 71. Europe Antibiotics Sales by Country (2017-2022) & (K Units)
Table 72. Europe Antibiotics Sales by Country (2023-2028) & (K Units)
Table 73. Europe Antibiotics Revenue by Country (2017-2022) & (US$ Million)
Table 74. Europe Antibiotics Revenue by Country (2023-2028) & (US$ Million)
Table 75. Asia Pacific Antibiotics Sales by Type (2017-2022) & (K Units)
Table 76. Asia Pacific Antibiotics Sales by Type (2023-2028) & (K Units)
Table 77. Asia Pacific Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 78. Asia Pacific Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 79. Asia Pacific Antibiotics Sales by Application (2017-2022) & (K Units)
Table 80. Asia Pacific Antibiotics Sales by Application (2023-2028) & (K Units)
Table 81. Asia Pacific Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 82. Asia Pacific Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 83. Asia Pacific Antibiotics Sales by Region (2017-2022) & (K Units)
Table 84. Asia Pacific Antibiotics Sales by Region (2023-2028) & (K Units)
Table 85. Asia Pacific Antibiotics Revenue by Region (2017-2022) & (US$ Million)
Table 86. Asia Pacific Antibiotics Revenue by Region (2023-2028) & (US$ Million)
Table 87. Latin America Antibiotics Sales by Type (2017-2022) & (K Units)
Table 88. Latin America Antibiotics Sales by Type (2023-2028) & (K Units)
Table 89. Latin America Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 90. Latin America Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 91. Latin America Antibiotics Sales by Application (2017-2022) & (K Units)
Table 92. Latin America Antibiotics Sales by Application (2023-2028) & (K Units)
Table 93. Latin America Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 94. Latin America Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 95. Latin America Antibiotics Sales by Country (2017-2022) & (K Units)
Table 96. Latin America Antibiotics Sales by Country (2023-2028) & (K Units)
Table 97. Latin America Antibiotics Revenue by Country (2017-2022) & (US$ Million)
Table 98. Latin America Antibiotics Revenue by Country (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Antibiotics Sales by Type (2017-2022) & (K Units)
Table 100. Middle East and Africa Antibiotics Sales by Type (2023-2028) & (K Units)
Table 101. Middle East and Africa Antibiotics Revenue by Type (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Antibiotics Revenue by Type (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Antibiotics Sales by Application (2017-2022) & (K Units)
Table 104. Middle East and Africa Antibiotics Sales by Application (2023-2028) & (K Units)
Table 105. Middle East and Africa Antibiotics Revenue by Application (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Antibiotics Revenue by Application (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Antibiotics Sales by Country (2017-2022) & (K Units)
Table 108. Middle East and Africa Antibiotics Sales by Country (2023-2028) & (K Units)
Table 109. Middle East and Africa Antibiotics Revenue by Country (2017-2022) & (US$ Million)
Table 110. Middle East and Africa Antibiotics Revenue by Country (2023-2028) & (US$ Million)
Table 111. Pfizer Corporation Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Pfizer Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Janssen Pharmaceuticals Corporation Information
Table 117. Janssen Pharmaceuticals Description and Major Businesses
Table 118. Janssen Pharmaceuticals Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Janssen Pharmaceuticals Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Janssen Pharmaceuticals Recent Developments
Table 121. Abbott Corporation Information
Table 122. Abbott Description and Major Businesses
Table 123. Abbott Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. Abbott Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Abbott Recent Developments
Table 126. GlaxoSmithKline Corporation Information
Table 127. GlaxoSmithKline Description and Major Businesses
Table 128. GlaxoSmithKline Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. GlaxoSmithKline Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. GlaxoSmithKline Recent Developments
Table 131. Sanofi Corporation Information
Table 132. Sanofi Description and Major Businesses
Table 133. Sanofi Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Sanofi Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Sanofi Recent Developments
Table 136. Novartis Corporation Information
Table 137. Novartis Description and Major Businesses
Table 138. Novartis Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Novartis Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Novartis Recent Developments
Table 141. Bayer Corporation Information
Table 142. Bayer Description and Major Businesses
Table 143. Bayer Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. Bayer Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Bayer Recent Developments
Table 146. Bristol Myers Squibb Company Corporation Information
Table 147. Bristol Myers Squibb Company Description and Major Businesses
Table 148. Bristol Myers Squibb Company Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 149. Bristol Myers Squibb Company Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Bristol Myers Squibb Company Recent Developments
Table 151. Eli Lilly and Company Corporation Information
Table 152. Eli Lilly and Company Description and Major Businesses
Table 153. Eli Lilly and Company Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 154. Eli Lilly and Company Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Eli Lilly and Company Recent Developments
Table 156. Astellas Pharma Corporation Information
Table 157. Astellas Pharma Description and Major Businesses
Table 158. Astellas Pharma Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 159. Astellas Pharma Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Astellas Pharma Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Antibiotics Distributors List
Table 164. Antibiotics Customers List
Table 165. Antibiotics Market Trends
Table 166. Antibiotics Market Drivers
Table 167. Antibiotics Market Challenges
Table 168. Antibiotics Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibiotics Product Picture
Figure 3. Global Antibiotics Market Share by Type in 2021 & 2028
Figure 3. Cephalosporins Product Picture
Figure 4. Penicillins Product Picture
Figure 5. Fluoroquinolones Product Picture
Figure 6. Macrolides Product Picture
Figure 7. Carbapenems Product Picture
Figure 8. Aminoglycosides Product Picture
Figure 9. Sulfonamides Product Picture
Figure 10. Others Product Picture
Figure 11. Global Antibiotics Market Share by Application in 2021 & 2028
Figure 12. Hospital
Figure 13. Clinics
Figure 14. Others
Figure 15. Antibiotics Report Years Considered
Figure 16. Global Antibiotics Sales 2017-2028 (K Units)
Figure 17. Global Antibiotics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Antibiotics Revenue 2017-2028 (US$ Million)
Figure 19. Global Antibiotics Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Antibiotics Sales Market Share by Region (2017-2022)
Figure 21. Global Antibiotics Sales Market Share by Region (2023-2028)
Figure 22. North America Antibiotics Sales YoY (2017-2028) & (K Units)
Figure 23. North America Antibiotics Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Antibiotics Sales YoY (2017-2028) & (K Units)
Figure 25. Europe Antibiotics Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Antibiotics Sales YoY (2017-2028) & (K Units)
Figure 27. Asia-Pacific Antibiotics Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Antibiotics Sales YoY (2017-2028) & (K Units)
Figure 29. Latin America Antibiotics Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Antibiotics Sales YoY (2017-2028) & (K Units)
Figure 31. Middle East & Africa Antibiotics Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Antibiotics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Antibiotics in the World: Market Share by Antibiotics Revenue in 2021
Figure 34. Global Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Antibiotics Sales Market Share by Type (2017-2028)
Figure 36. Global Antibiotics Revenue Market Share by Type (2017-2028)
Figure 37. Global Antibiotics Sales Market Share by Application (2017-2028)
Figure 38. Global Antibiotics Revenue Market Share by Application (2017-2028)
Figure 39. North America Antibiotics Sales Market Share by Type (2017-2028)
Figure 40. North America Antibiotics Revenue Market Share by Type (2017-2028)
Figure 41. North America Antibiotics Sales Market Share by Application (2017-2028)
Figure 42. North America Antibiotics Revenue Market Share by Application (2017-2028)
Figure 43. North America Antibiotics Sales Share by Country (2017-2028)
Figure 44. North America Antibiotics Revenue Share by Country (2017-2028)
Figure 45. U.S. Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Antibiotics Sales Market Share by Type (2017-2028)
Figure 48. Europe Antibiotics Revenue Market Share by Type (2017-2028)
Figure 49. Europe Antibiotics Sales Market Share by Application (2017-2028)
Figure 50. Europe Antibiotics Revenue Market Share by Application (2017-2028)
Figure 51. Europe Antibiotics Sales Share by Country (2017-2028)
Figure 52. Europe Antibiotics Revenue Share by Country (2017-2028)
Figure 53. Germany Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 54. France Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Antibiotics Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Antibiotics Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Antibiotics Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Antibiotics Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Antibiotics Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Antibiotics Revenue Share by Region (2017-2028)
Figure 64. China Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 67. India Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Antibiotics Sales Market Share by Type (2017-2028)
Figure 75. Latin America Antibiotics Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Antibiotics Sales Market Share by Application (2017-2028)
Figure 77. Latin America Antibiotics Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Antibiotics Sales Share by Country (2017-2028)
Figure 79. Latin America Antibiotics Revenue Share by Country (2017-2028)
Figure 80. Mexico Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Antibiotics Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Antibiotics Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Antibiotics Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Antibiotics Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Antibiotics Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Antibiotics Revenue Share by Country (2017-2028)
Figure 89. Turkey Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 91. U.A.E Antibiotics Revenue (2017-2028) & (US$ Million)
Figure 92. Antibiotics Value Chain
Figure 93. Antibiotics Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs